This paper is in the following e-collection/theme issue:

Chatbots and Conversational Agents (458) Consumer & Patient Education and Shared-Decision Making (636) Breast Cancer (200) Emotional, Social, Psychological Support for Cancer (188) Patient Education for Cancer (138)

Published on in Vol 21, No 11 (2019): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15787, first published .
A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial

A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial

A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial

Authors of this article:

Jean-Emmanuel Bibault1 Author Orcid Image ;   Benjamin Chaix2, 3 Author Orcid Image ;   Arthur Guillemassé3 Author Orcid Image ;   Sophie Cousin4 Author Orcid Image ;   Alexandre Escande5 Author Orcid Image ;   Morgane Perrin6 Author Orcid Image ;   Arthur Pienkowski3 Author Orcid Image ;   Guillaume Delamon3 Author Orcid Image ;   Pierre Nectoux3 Author Orcid Image ;   Benoît Brouard3 Author Orcid Image
Article Authors Cited by (90) Tweetations (9) Metrics

Jean-Emmanuel Bibault   1 * , MD, PhD ;   Benjamin Chaix   2, 3 * , MSc ;   Arthur Guillemassé   3 , MSc ;   Sophie Cousin   4 , MSc, MD ;   Alexandre Escande   5 , MSc, MD ;   Morgane Perrin   6 , MSc, MD ;   Arthur Pienkowski   3 , PharmD ;   Guillaume Delamon   3 , PharmD ;   Pierre Nectoux   3 , MSc ;   Benoît Brouard   3 , PharmD

1 Department of Radiation Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

2 ENT Department, Hôpital Gui de Chauliac, Université Montpellier 1, Montpellier, France

3 Wefight, Institut du Cerveau et de la Moelle épinière, Hôpital Pitié-Salpêtrière, Paris, France

4 Department of Medical Oncology, Institut Bergonié, Bordeaux, France

5 Department of Radiation Oncology, Centre Oscar Lambret, Lille, France

6 Department of Gynecological Oncologic Surgery, Gustave Roussy Cancer Campus, Villejuif, France

*these authors contributed equally

Corresponding Author: